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ABSTRACS 
This study examines the physically modified gellan gum in tablet formulation i.e., as a 
superdisintegrant. Physical cross-liking of gellan gum was carried out using microwave energy and it 
was subjected to Differential Scanning Calorimetry and Fourier Transform – Infra Red. Swelling ratio 
of pure and modified gellan gum was performed. Tablets of were formulated containing modified 
gellan gum using 32 randomized full factorial designs. It was observed that physical modification on 
gellan gum was done by microwave energy and was confirmed by Differential Scanning Calorimetry 
and Fourier Transform – Infra Red. Modified gellan gum has superior swelling ratio than pure. It was 
observed that optimized batch shows excellent disintegration time (155 s), and % drug release in 2 and 
5 min were 39 and 78%, respectively. It was concluded that there was a no chemical interactions while 
only physical modification and modified gellan gum can work as a superdisintegrant.   
 
KEYWORDS: Factorial Design, Gellan gum, Physical Modification. 
1. INTRODUCTION 
Carbohydrate polymers have been widely employed in the formulation of pharmaceutical 
solid dosage form. The wide applications of these biopolymers are attributed to their 
biodegradability and no oral toxicity. Gellan gum (commercially available as Gelrite
TM or 
Kelcogel
TM) is a gel forming polysaccharide produced by the microbe Sphingomonas elodea 
(formerly Pseudomonas elodea) and approved for food use by the FDA in 1992
1-2. Gellan 
polymer consists of monosaccharide  α-L-rhamnose, β-D-glucuronic acid and β-D-glucose in 
molar ratio of 1:1:2 linked together to form a linear primary structure
3.
 Gellan gels have 
previously been examined for application in ophthalmic drug delivery
4-6, oral sustained 
delivery
7-8, gellan beads
9, sustained delivery beads
10, controlled release hydrogel with 
scleroglucan
11-12, and floating in situ gelling
13. 
Diclofenac sodium, a potential non-steroidal anti-inflammatory drug with pronounced 
analgesic properties, is used in the long-term treatment of rheumatoid arthritis, osteoarthritis 
and ankylosing spondylitits. Its biological half-life has been reported as 1 –2 h
14-15. 
 
Aceclofenac, chemically [[2-[(2, 6 – Dichlorophenyl) amino phenyl] acetyl] oxy] acetic acid, 
is a new analgesic and anti-inflammatory drug used in the management of osteoarthritis, SHAH DP. A Newer Application of Physically Modified Gellan Gum …   29 
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rheumatoid arthritis and ankylosing spondylitis
16.  
Since the implementation of polymeric materials in the field of pharmaceutical technology, 
numerous attempts have been undertaken to modify their physical and chemical properties, 
and thus their potential applicability into various fields of drug formulation. Temperature has 
been one of the most favorable methods of cross-linking because it avoids both the 
application of harsh chemical materials suitable for large-scale production and the diversity of 
equipments and methods used in their application
17. 
The microwave consists of a non-thermal component, in addition to its thermal effects. 
Microwave is a high frequency radiation (300 MHz to 30 GHz), which possesses both 
electrical and magnetic properties. The state of molecular interaction of an object may change 
in its physicochemical properties with time
18-19. Recently, the use of microwave in the 
pharmaceutical industry is a growing interest. Various applications of microwave technology 
are being used like drying of pharmaceutical excipient
20, granules
21-22, film coats
23,
  and 
formulation of controlled release beads
24.  
The cross-linking of natural macromolecules with microwave energy should have the 
potentiality to overcome problems of toxicity resulting from remaining traces of chemical 
cross-linking agents and of the in vivo biodegradation products of the chemically cross-linked 
macromolecules. Identification of new uses for the existing excipient is a relatively 
inexpensive and less involving process as compared to an entirely new development. In 
developing the new grades of existing excipient, the physical characteristics of the materials 
are to be modified while the chemical nature is preserved to a large extent. 
Microwave heating, as an alternative to conventional heating technology, has been proved 
to be more rapid and efficient. The development of microwave-assisted cross-linking of 
polymer, has witnessed an explosive growth during the last decades. In present study, 
modification of gellan gum was carried out by microwave energy and was used in tablet 
formulation. Confirmation of modification was performed by Differential Scanning 
Calorimetry (DSC) and Fourier Transform – Infra Red (FT-IR) study. Optimization of the 
amount and mode of addition of disintegrant was carried out with the help of 3
2 full factorial 
designs in Diclofenac tablets. Various parameters like disintegration time, hardness, friability 
and dissolution rate study were carried out. A comparison between modified gellan gum and 
sodium starch glycolate was carried out. Finally, stability study of optimized batch was 
carried out at 40
0C and 75% RH for three months. 
2. MATERIALS AND METHODS 
2.1 Materials 
Gellan gum was received as gift sample from C P Kelco, Mumbai, India. Diclofenac 
sodium (DS), Sodium Starch Glycolate (SSG) was also received as gift sample from Colorcon 
India. Dibasic calcium phosphate (DCP) IP, Lactose monohydrate IP, Polyvinyl pyrollidone SHAH DP. A Newer Application of Physically Modified Gellan Gum …   30 
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(PVP), Talc IP and Mg-stearate IP were used as received. All other solvents and chemicals 
were of AR grade. Deionized double distilled water was used through out the study. 
2.2 Modification of Gellan gum by Microwave  
An accurately weighed pure gellan gum (PGG) and de-ionized water was heated until the 
complete hydration of gum was obtained. Aqueous hot solution was pouring in a lidless glass 
Petri dish and cools it to room temperature. PGG and distilled water was exposed in 
microwave for 12 min with 80 ml of distilled water in microwave at 700 W (Model MS-
1921HE, LG Electronics Inc. India). Dried material (Modified Gellan Gum = MGG) was 
collected and passed through sieve no. 85 and was preserved in dessicator for further study.  
2.3 Swelling Ratio
 
The study was carried out in 100ml stopper graduated cylinder. The initial bulk volume of 
1g MGG was noted and then water added in sufficient quantity to yield 100 ml uniform 
dispersion. The sediment volume of the swollen mass was noted after 24 hr at room temp. The 
swelling ratio was calculated by taking the ratio of the swollen volume to the initial bulk 
volume
25. The mean of three observations were taken. 
2.4 Characterization of MGG by Differential scanning Calorimetry & Fourier 
transforms infra-red spectroscopy 
2.4.1 Differential scanning calorimetry  
DSC thermograms were obtained using a differential scanning calorimeter (Model TA-60, 
Shimadzu, Japan); about 2mg of sample were scanned in a hermetically sealed standard 
aluminum pan and heated over the temperature range between 50 and 300
0C at a heating rate 
of 10
0C/min under constant purging of nitrogen at 40 ml/min. An empty sealed aluminum pan 
was used as a reference. The characteristic peaks and specific heat of the melting endotherm 
were recorded.  
2.4.2. Fourier transforms infra-red spectroscopy  
About 2% (w/w) of sample (PGG and MGG), with respect to the potassium bromide (KBr) 
disc, was mixed with dry KBr (FT-IR grade). The mixture was ground into a fine powder 
before compressing into a disc. Each disc was scanned at a resolution of 4cm
-1 over a wave 
number region of 400-4000cm
-1 using a FT-IR spectrometer (Spectrum GX FTIR System, 
Perkin Elmer, USA). The characteristic peaks of IR transmission spectra were recorded.   
2.5 Preparation of Diclofenac sodium Tablets 
All ingredients were passed through a 60-mesh sieve; it was than granulated using 10% 
wt/vol solution of PVP. The wet coherent mass was passed through a 20-mesh sieve. The wet 
granules were dried at 60ºC in a tray dryer. The dried granules were passed through a 22-SHAH DP. A Newer Application of Physically Modified Gellan Gum …   31 
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mesh sieve. Fines were removed by sifting the granules on a 44-mesh sieve. The powder 
blend was then lubricated with talc. Lubrication was done in a glass jar for 2 min
26. Tablets 
were prepared on a rotary tablet press using flat-faced punches and die (Model Rimek-II, 
Karnavati Engg., Ahmedabad). The turret was rotated at a fixed speed of 30 rpm. 
The experimental design was 3
2 full-factorial design and 9 formulations were prepared 
using two factors and at three levels. Experimental designs are shown in Table 1. The two 
independent variables were mode of addition (X1) and the amount of disintegrant (X2). The 
low (-1), medium (0), and high (+1) values of X1 are extra-granular, extra plus intra-granular 
in ratio of 1:1 and intra-granular mode of addition of disintegrating agent; while values of X2 
were 4.5, 7.5 and 12mg, respectively. The compositions of the nine batches (Batches IA to II) 
are shown in Table 2. The DT, percentage drug release in 2 & 5 min were selected as 
dependent variables.  
Table 1. Factorial design of tablets containing Diclofenac. 
% Drug Release In  Batch Code  X1  X2  Disintegration Time 
(s)  2 Min  5 Min 
IA  -1  -1  600  12  22 
IB  0  -1  560  16  30 
IC  1  -1  500  18  40 
ID  -1  0  360  22  46 
IE  0  0  300  24  53 
IF  1  0  240  25  55 
IG  -1  1  210  26  65 
IH  0  1  175  32  75 
II  1  1  155  39  78 
              
Table 2. Tablet formulation of MGG containing Diclofenac. 
Ingredients (mg) 
/ Batch Code  IA  IB  IC  ID  IE  IF  IG  IH  II 
DS  50  50  50  50  50  50  50  50  50 
DCP  73  73  73  70  70  70  65.5  65.5  65.5 
MGG  
(extra-granular)  4.5  2.25  ---  7.5  3.75  ---  12  6  --- 
MGG  
(intra-granular)  ---  2.25  4.5  ---  3.75  7.5  ---  6  12 
PVP (10 % w/v )  15  15  15  15  15  15  15  15  15 
Talc  7.5  7.5  7.5  7.5  7.5  7.5  7.5  7.5  7.5 
Total  150  150  150  150  150  150  150  150  150 
---- indicates excipient not included in formulation. SHAH DP. A Newer Application of Physically Modified Gellan Gum …   32 
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2.6 Preparation of DS tablets containing SSG 
A comparison between MGG and SSG was carried out. DS tablets were prepared by wet 
granulation. DS containing MGG (Batch IDM) and SSG (Batch IDS) were prepared. 
Disintegrant added intra-granular. All steps of tablets formulations are same as mentioned 
above. Formulations are shown in Table 3. 
Table 3. Formulation of DS tablets containing MGG and SSG. 
Batch Code 
Ingredients (mg) 
IDM  IDS 
DS  50  50 
DCP  65.5  65.5 
MGG  12  - 
SSG  -  12 
PVP   15  15 
Talc  7.5  7.5 
Total  150  150 
2.7 Disintegration Time (DT) 
The time required for disintegration of six tablets per batch was carried out in USP 
disintegration test apparatus (Model ED2L, Electrolab, Mumbai, India) containing 900 ml 
distilled water at 37+0.5
0C. The mean DT was calculated.  
2.8 Hardness and Friability test  
Monsanto Hardness Tester was used to measure hardness of tablets (n =5). Friability was 
evaluated as the percentage weight loss of 20 tablets tumbled in a friabilator (USP XXIII, 
Model EF2, Electrolab, Mumbai) for 4 minutes at 25 rpm. The tablets were dedusted, and the 
loss in weight caused by fracture or abrasion was recorded as percentage friability.  
2.9 Dissolution Rate Study 
The drug release study was carried out using USP XXIII paddle type dissolution test 
apparatus (Model TDL-08, Electrolab, Mumbai) at 37+0.5
0C and at 50 rpm using 900mL 
distilled water as dissolution medium (n=5). Five milliliters sample solution was withdrawn at 
predetermined time intervals, filtered through a 0.45 micron membrane filter, diluted suitably, SHAH DP. A Newer Application of Physically Modified Gellan Gum …   33 
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and analyzed spectrophotometrically at 276nm using a Shimazdu-1700 UV-Visible double 
beam spectrophotometer. Equal amounts of fresh dissolution medium were replaced 
immediately after withdrawal of a test sample. The percentage drug dissolved at different time 
intervals was calculated using regression equation generated from the standard curve.  
2.10 Stability Study 
To study the effect of storage on DT and hardness, stability study of best formulation 
(Batch II) was carried out at 40
0C and 75% RH in a humidity oven. Samples were withdrawn 
after three-month interval and were evaluated for change in DT and hardness. 
3. RESULTS & DISCUSSIONS 
3.1 Modification of Gellan Gum 
Physical modification pure gellan gum was carried out using microwave energy. PGG was 
treated only with distilled water without usage of any other material/chemicals. PGG and 
distilled water was exposed in microwave for 12 min with 80 ml of distilled water. At low 
temperature gellan form an ordered helix of double strands, while at high temperature single 
stranded polysaccharides occurs, which significantly reduce the viscosity of solution. In our 
preliminary studies, we observed that the viscosity of PGG was reduced when it was exposed 
to high temperature. Hence, in the present study, a modified form was prepared by exposing 
PGG in microwave oven at higher temperature for different time periods.  
The native polymer is high acyl gellan containing O-5-acetyl and O-2-glyceryl groups on 
the (1-3)-linked glucose residue. High acyl gellan gels are very weak because of the bulky 
acetyl and glyceryl groups that prevent close association between gellan polymer chains in 
double-helix formation and hinder compact packing of the cross-linked double helix. The 
results of physical changes attributed to PGG upon modification shows marked decreased in 
viscosity as well as gelling ability. The MGG possesses excellent swelling property but lesser 
viscosity; this may be because of formation of single stranded polysaccharides at higher 
temperature
27-29. 
To confirm physical modification, MGG was subjected to DSC and FT-IR. Figure 1 (a) & 
(b) depicts the physical state characteristic of PGG and MGG. The thermogram of PGG 
exhibit endothermic peak at 88.16
oC and 270.5
oC, however, it was slightly shifted to higher 
temperature 94.35
oC and 284.29
oC in MGG. In addition, a single exothermic peak was 
observed at 262.8
oC in PGG and was slightly shifted to lower temperature 259.73
oC in MGG.  
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Figure 2. FT-IR Spectra of (a) Pure Gellan Gum and (b) Modified Gellan Gum. 
 
FT-IR studies were performed to check whether the samples had undergone any chemical 
degradation or modification or change or not. The FT-IR spectra of PGG are shown in Figure 
2 (a) shows characteristics peaks at ~1736 cm
-1 for carbonyl group indicating C = O 
stretching, strong bond at ~ 3400 cm
-1 for OH group, band at 2800 – 3000 cm
-1 for C – H 
stretching, band at ~ 1380 cm
-1 for methyl C – H banding and band at ~1060 – 1150 cm
-1 for 
C – O stretching for alky ether. Figure 2 (b) exhibit FT-IR spectra of MGG, shows similar 
characteristics peaks.  
The DSC analysis showed that energy requirement was found to be different for PGG and SHAH DP. A Newer Application of Physically Modified Gellan Gum …   35 
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MGG indicating modification of properties and this change are only in physical state. There 
was a no major changes in peaks observed in PGG (Figure 1 (a)) and MGG (Figure 1 (b)) 
which indicates that there was no chemical change observed after microwave treatment. It 
was stated that in microwave treatment high energy is used. So, there may be a chance of 
chemical degradation/changes of PGG during microwave treatment. It was observed that there 
was a same functional group present before and after microwave treatment. Hence, it may be 
concluded that the gellan gum had not degraded during/ after microwave treatment or there 
was a no chemical degradation or change or modification observed in MGG. So, safety of 
material i.e., MGG, retain as such throughout the microwave treatment. It was concluded that 
high energy (treatment in microwave) did not affect the chemical characteristics of gellan 
gum. 
3.2 Swelling ratio 
Swelling ratio of PGG was found to be (19 + 1.112, 16 + 0.985 and 14 + 0.875) in distilled 
water, HCl and phosphate buffer, respectively, while swelling ratio of MGG was found to be 
(22 + 1.222, 18 + 1.002 and 16 + 0.835) in distilled water, HCl and phosphate buffer, 
respectively. 
It was concluded from the results of swelling ratio that PGG was found to be highly 
viscous in nature, while MGG showed drastic drop in viscosity. Swelling ratios of MGG were 
increased marginally as compared to PGG. It was confirmed that there was a change in its 
physical property i.e., viscosity.  
3.3 Optimization results 
A statistical model incorporating interactive and polynomial terms was utilized to evaluate 
the response.  
Y = b0 + b1X1 + b2X2 + b12X1X2 + b11X1
2 + b22X2
2     (1) 
Where, Y is the dependent variable, b0 is the arithmetic mean response of the nine runs, 
and bi is the estimated coefficient for the factor X1. The main effects (X1 and X2) represent 
the average result of changing one factor at a time from its low to high value. The interaction 
terms (X1X2) show how the response changes when two factors are simultaneously changed. 
It may be used to obtain reasonable estimate of the response since small error of variance was 
noticed in the replicates. The polynomial equation can be used to draw conclusions after 
considering the magnitude of coefficient and the mathematical sign it carries, i.e., positive or 
negative. The data demonstrate that both the factors (X1 and X2) affect the dependent 
variables. The low value X1X2 of coefficient also suggests that the interaction between X1 and 
X2 is not significant
30. The data analysis of factorial design was carried out by Microsoft 
Excel 2007. 
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Figure 2. FT-IR Spectra of (a) Pure Gellan Gum and (b) Modified Gella Gum. 
 
A 3
2 full-factorial design and 9 formulations were prepared using two factors and at three 
levels. The two independent variables were mode of addition (X1) and the amount of 
disintegrant (X2). The low (-1), medium (0), and high (+1) values of X1 are extra-granular, 
extra plus intra-granular in ratio of 1:1 and intra-granular mode of addition of disintegrant; 
while values of X2 were 4.5, 7.5 and 12 mg, respectively. The design layout and results for 
DS tablets are shown in Table 1. The results reveal that the DT and percentage drug release in 
2 and 5 min were strongly influenced by the mode of addition of disintegrant (X1) and amount SHAH DP. A Newer Application of Physically Modified Gellan Gum …   37 
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of disintegrant (X2). A summary of regression output are summarized in following equations.  
 
Equations (2), (3) and (4) represent the regression output for dependent variable DT, drug 
release in 2 and 5 min, respectively. 
YDT = 300.55 – 45.83 X1 – 186.67 X2 - 0.83 X1
2   + 66.66 X2
2 + 11.25 X1X2           
       ( 2 )
 
(r
2 =
 0.9969, DF = 8, F = 196.69)
        
Ydr2 = 23.88 + 3.66 X1 + 8.5 X2 - 0.33 X1
2   - 0.16 X2
2 + 1.75 X1X2     
                    (3) 
(r
2 =
 0.9725, DF = 8, F = 21.26) 
Ydr5 = 52.44 + 6.66 X1 + 21.0 X2 – 1.66 X1
2 + 0.33 X2
2 - 1.25 X1X2     
              (4) 
(r
2 =
 0.9926, DF = 8, F = 81.51) 
DT and drug release in 2 and 5 min value for the nine batches (Batches IA to II) showed a 
wide variation 155 to 600 s, 12 to 39% and 22 to 78%, respectively.  The results reveal that 
the DT and percentage drug release in 2 and 5 min were strongly influenced by the mode of 
addition of disintegrant (X1) and amount of disintegrant (X2). The value of correlation 
coefficient of DT, %drug release in 2 and 5 min, were found to be 0.9969, 0.9725 and 0.9926, 
respectively, indicating a good fit. Different formulations of DS tablets were prepared 
according to factorial design shown in Table 1. It was found that both variables mode of 
addition of disintegrant (X1) and amount of  disintegrant (X2) have negative impact on DT 
(Equation - 2), as the amount of disintegrant increases there was a decrease in DT, while 
variable X1 and X2 have positive impact on drug release in 2 & 5 min (Equation - 3 & 4), 
respectively. As the amount of disintegrant increases there was an increase in drug 
dissolution. Further, it was observed that intra-granular addition of disintegrant shows 
remarkable decrease in DT as compared to extra-granular and extra plus intra-granular in 
ration of 1:1. Batches II, showed lesser DT (155 s) and excellent % drug release in 2 and 5 
min (39 & 78 %), respectively, as compared to other batches. This may be because of higher 
amount of disintegrant and intra-granular - mode of addition of disintegrant. So, batch II, was 
concluded as optimized batch. 
3.4 Comparative Study with SSG 
A comparison of MGG was carried out with well accepted super disintegrating agent SSG 
by preparing the tablets of DS. Results are shown in Table 4. It was observed that DT of DS 
tablets containing MGG (Batch IDM) and SSG (Batch IDS) was found to be 155 and 175 s, SHAH DP. A Newer Application of Physically Modified Gellan Gum …   38 
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respectively. It was observed that MGG containing tablet shows lesser DT as compared to 
SSG. MGG will draw more water, swells and break tablets faster. All tablets have acceptable 
hardness and friability. 
Table 3. Formulation of DS tablets containing MGG and SSG. 
Batch Code 
Ingredients (mg) 
IDM  IDS 
DS  50  50 
DCP  65.5  65.5 
MGG  12  - 
SSG  -  12 
PVP   15  15 
Talc  7.5  7.5 
Total  150  150 
3.5 Stability Study  
Finally, stability study of optimized batch (Batch II) was carried out at 40
0C and 75% RH 
in a humidity oven. Samples were withdrawn after three-month interval and evaluated for 
change in hardness and DT. It was found that there was little softening of tablets, so hardness 
of tablets were reduced from 5 to 4.5 kg/cm
2 and some increase in DT from 155 to 172 s, 
respectively. It was observed that there was a no significant effect of such environment on 
tablets prepared from MGG and was concluded that tablets of DS are stable after stability 
study.  
The areas where further work can be done include using a fluid bed dryer or spray dryer 
for preparation of modified excipient, using different combinations and ratios with widely 
accepted super disintegrating agent like crospovidone, SSG and croscarmellose. 
4. CONCLUSION 
It was concluded that after microwave treatment there was only physical modification of 
gellan gum as well as there was no chemical degradation or changes in gellan gum. MGG 
exhibited excellent swelling ratio in all three media. DS tablets show quicker disintegration, 
acceptable hardness and friability as well as faster drug dissolution when intra-granular mode 
of addition of disintegrant (modified gellan gum). It was concluded that MGG containing 
tablet shows better results as compared to SSG. Finally, results of stability study showed that 
MGG was not affected by specified environmental conditions. It can be concluded that MGG SHAH DP. A Newer Application of Physically Modified Gellan Gum …   39 
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could be worked as a superdisintegrant in tablet formulation. 
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